ESC Premium Access

Interim analysis of data from a long-term, extension trial of tafamidis meglumine in patients with transthyretin amyloid cardiomyopathy

Congress Presentation

About the speaker

Professor Stephen Gottlieb

University of Maryland, Baltimore (United States of America)
0 follower

8 more presentations in this session

Role of 18FDG(fluorodeoxyglucose)-PET (positron emission tomography) for differential diagnosis of pericardial disease

Speaker: Doctor C. Hyeon (Seoul, KR)


Tafamidis versus liver transplantation as first-line therapy for hereditary transthyretin amyloidosis

Speaker: Doctor V. Algalarrondo (Paris, FR)


Myocardial perfusion mapping in cardiac amyloidosis- exploring the spectrum from infiltration to ischaemia

Speaker: Doctor T. Kotecha (London, GB)


The increased serum level of troponin T after immunosuppression therapy reflects sustained myocardial FDG accumulation in cardiac sarcoidosis

Speaker: Doctor R. Morimoto (Nagoya, JP)


Anti-heart and anti-intercalated disk autoantibodies: possible novel biomarkers of cardiac sarcoidosis

Speaker: Professor A. Caforio (Padova, IT)


Access the full session

Hot topics in myocardial and pericardial diseases

Speakers: Professor S. Gottlieb, Doctor C. Hyeon, Doctor V. Algalarrondo, Doctor T. Kotecha, Doctor R. Morimoto...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb